JP2013526863A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2013526863A5 JP2013526863A5 JP2013509571A JP2013509571A JP2013526863A5 JP 2013526863 A5 JP2013526863 A5 JP 2013526863A5 JP 2013509571 A JP2013509571 A JP 2013509571A JP 2013509571 A JP2013509571 A JP 2013509571A JP 2013526863 A5 JP2013526863 A5 JP 2013526863A5
- Authority
- JP
- Japan
- Prior art keywords
- genes
- cell carcinoma
- renal cell
- discontinuous
- sample
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US33431810P | 2010-05-13 | 2010-05-13 | |
| EP10162783.4 | 2010-05-13 | ||
| EP10162783 | 2010-05-13 | ||
| US61/334,318 | 2010-05-13 | ||
| PCT/EP2011/057691 WO2011141544A1 (en) | 2010-05-13 | 2011-05-12 | Discrete states for use as biomarkers |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2013526863A JP2013526863A (ja) | 2013-06-27 |
| JP2013526863A5 true JP2013526863A5 (https=) | 2014-06-19 |
Family
ID=43127799
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013509571A Withdrawn JP2013526863A (ja) | 2010-05-13 | 2011-05-12 | バイオマーカーとして用いるための不連続状態 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20130157887A1 (https=) |
| EP (1) | EP2569636A1 (https=) |
| JP (1) | JP2013526863A (https=) |
| CA (1) | CA2798434A1 (https=) |
| WO (1) | WO2011141544A1 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7838250B1 (en) | 2006-04-04 | 2010-11-23 | Singulex, Inc. | Highly sensitive system and methods for analysis of troponin |
| JP5308328B2 (ja) | 2006-04-04 | 2013-10-09 | シングレックス，インコーポレイテッド | トロポニンの分析のための高感度のシステムおよび方法 |
| WO2010144358A1 (en) | 2009-06-08 | 2010-12-16 | Singulex, Inc. | Highly sensitive biomarker panels |
| EP3722444B1 (en) * | 2019-04-12 | 2024-06-05 | Robert Bosch Gesellschaft für medizinische Forschung mbH | Method for determining rcc subtypes |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2624863T3 (es) * | 2005-06-08 | 2017-07-17 | Millennium Pharmaceuticals, Inc. | Métodos para identificación, evaluación, y tratamiento de pacientes con terapia de cáncer |
| US20100222230A1 (en) * | 2007-04-11 | 2010-09-02 | The General Hospital Corporation | Diagnostic and prognostic methods for renal cell carcinoma |
-
2011
- 2011-05-12 US US13/697,419 patent/US20130157887A1/en not_active Abandoned
- 2011-05-12 EP EP11719551A patent/EP2569636A1/en not_active Withdrawn
- 2011-05-12 JP JP2013509571A patent/JP2013526863A/ja not_active Withdrawn
- 2011-05-12 WO PCT/EP2011/057691 patent/WO2011141544A1/en not_active Ceased
- 2011-05-12 CA CA2798434A patent/CA2798434A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Remon et al. | Osimertinib benefit inEGFR-mutant NSCLC patients withT790M-mutation detected by circulating tumour DNA | |
| Olmos et al. | Circulating tumour cell (CTC) counts as intermediate end points in castration-resistant prostate cancer (CRPC): a single-centre experience | |
| Steenaard et al. | Tobacco smoking is associated with methylation of genes related to coronary artery disease | |
| US20220056541A1 (en) | Method for predicting response to breast cancer therapeutic agents and method of treatment of breast cancer | |
| CA3109391A1 (en) | Methods related to bronchial premalignant lesion severity and progression | |
| Ye et al. | The association of renin-angiotensin system genes with the progression of hepatocellular carcinoma | |
| JP2016500110A5 (https=) | ||
| CN105636594A (zh) | 使用雄激素靶向疗法用于治疗肿瘤性疾病的生物标记物 | |
| WO2009121031A4 (en) | Methods of novel therapeutic candidate identification through gene expression analysis in vascular-related diseases | |
| JP2011177182A5 (https=) | ||
| JP2009540314A5 (https=) | ||
| CN106148529A (zh) | 与胃癌相关的LncRNA标记物及其专用检测引物、检测方法、试剂盒与应用 | |
| JP2013526863A5 (https=) | ||
| Powrózek et al. | The diagnostic role of plasma circulating precursors of miRNA-944 and miRNA-3662 for non-small cell lung cancer detection | |
| Eskesen et al. | Low use of surveillance and early diagnosis of hepatocellular carcinoma in Norway—a population-based cohort study | |
| Li et al. | Increased serum FGF2 levels in first-episode, drug-free patients with schizophrenia | |
| Lu et al. | Integrated systems toxicology approaches identified the possible involvement of ABC transporters pathway in erythromycin estolate-induced liver injury in rat | |
| JP2012520446A5 (https=) | ||
| Wang et al. | Gene expression profiling analysis to investigate the role of remote ischemic postconditioning in ischemia-reperfusion injury in rats | |
| Strak et al. | A study of lichen planus and its association with hepatitis C infection | |
| Chen et al. | Sodium reduction, miRNA profiling and CVD risk in untreated hypertensives: A randomized, double-blind, placebo-controlled trial | |
| WO2010133881A3 (en) | Tissue analysis | |
| CN104164500B (zh) | miRNA标志物hsa-miR-486-5p的应用 | |
| Mulvenna et al. | Banking on the future: biobanking for “omics” approaches to biomarker discovery for Opisthorchis-induced cholangiocarcinoma in Thailand | |
| JP2015503106A5 (https=) |